Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
C.-C. D. Cho, S. G. Li, K. S. Yang, T. J. Lalonde, G. Yu, Y. Qiao, S. Xu, W. R. Liu
This study screens inhibitors against SARS-CoV-2 PLpro, identifying several potent compounds with IC50 values below 60 μM, including SJB2-043 with an IC50 of 0.56 μM.
bioRxiv · Jun 4, 2021Biochemistry